An important role of the BChE in the regulation of brain ACh levels in late AD [9,10] was pointed out based on findings that, during disease progression, AChE activity decreases to about 33–45% of its normal activity, while BChE activity progressively increases by about 40–90% of its normal activity [8]. The gene discussed is ACHE; the disease is Alzheimer disease.